Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 41
Titolo Data di pubblicazione Autore(i) File
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 1-gen-2010 Melisi, Davide; Xia, Q.; Moccia, T.; Paradiso, G.; Carbone, C.; Ling, J.; Abbruzzese, J. L.; Budillon, A.; Chiao, P. J.
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 1-gen-2011 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Simbolo, Michele; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 1-gen-2011 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 1-gen-2011 Carbone, C.; Moccia, T.; Zhu, C.; Paradiso, G.; Budillon, A.; Chiao, P. J.; Abbruzzese, J. L.; Melisi, Davide
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 1-gen-2011 Melisi, Davide; Xia, Q.; Paradiso, G.; Ling, J.; Moccia, T.; Carbone, C.; Budillon, A.; Abbruzzese, J. L.; Chiao, P. J.
NF-κB as a target for pancreatic cancer therapy. 1-gen-2012 Carbone, C.; Melisi, Davide
Rationale and clinical use of multitargeting anticancer agents. 1-gen-2013 Melisi, Davide; Piro, G.; Tamburrino, A.; Carbone, C.; Tortora, Giampaolo
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 1-gen-2013 Anna, Tamburrino; Piro, Geny; Carbone, Carmine; Tortora, Giampaolo; Melisi, Davide
Toll-Like Receptor 9 Agonists for Cancer Therapy 1-gen-2014 Melisi, Davide; Frizziero, Melissa; Tamburrino, Anna; Zanotto, Marco; Carbone, Carmine; Piro, Geny; Tortora, Giampaolo
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 1-gen-2015 Simionato, Francesca; Frizziero, Melissa; Carbone, Carmine; Tortora, Giampaolo; Melisi, Davide
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 1-gen-2015 Carbone, C; Piro, G; Fassan, Matteo; Tamburrino, A; Mina, Maria Mihaela; Zanotto, M; Chiao, Pj; Bassi, Claudio; Scarpa, Aldo; Tortora, Giampaolo; Melisi, Davide
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 1-gen-2015 Piro, Geny; Giacopuzzi, Simone; Bencivenga, Maria; Carbone, C; Verlato, Giuseppe; Frizziero, M; Zanotto, M; Mina, Maria Mihaela; Merz, V; Santoro, R; Zanoni, Andrea; DE MANZONI, Giovanni; Tortora, Giampaolo; Melisi, Davide
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 1-gen-2016 Piro, Geny; Carbone, Carmine; Cataldo, Ivana; Di Nicolantonio, Federica; Giacopuzzi, Simone; Aprile, Giuseppe; Simionato, Francesca; Boschi, Federico; Zanotto, Marco; Mina, Maria Mihaela; Santoro, Raffaela; Merz, Valeria; Sbarbati, Andrea; DE MANZONI, Giovanni; Scarpa, Aldo; Tortora, Giampaolo; Melisi, Davide
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 1-gen-2016 Carbone, Carmine; Tamburrino, Anna; Piro, Geny; Boschi, Federico; Cataldo, Ivana; Zanotto, Marco; Mina, Maria Mihaela; Zanini, Silvia; Sbarbati, Andrea; Scarpa, Aldo; Tortora, Giampaolo; Melisi, Davide
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 1-gen-2016 Brannon, A. Rose; Frizziero, Melissa; Chen, David; Hummel, Jennifer; Gallo, Jorge; Riester, Markus; Patel, Parul; Cheung, Wing; Morrissey, Michael; Carbone, Carmine; Cottini, Silvia; Tortora, Giampaolo; Melisi, Davide
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 1-gen-2017 Piro, Geny; Simionato, Francesca; Carbone, Carmine; Frizziero, Melissa; Malleo, Giuseppe; Zanini, SILVIA MARIA; Casolino, Raffaella; Santoro, Raffaela; Mina, Maria Mihaela; Zecchetto, Camilla; Merz, Valeria; Scarpa, Aldo; Bassi, Claudio; Tortora, Giampaolo; Melisi, Davide
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 1-gen-2017 Carbone, Carmine; Piro, Geny; Simionato, Francesca; Ligorio, Francesca; Cremolini, Chiara; Loupakis, Fotios; Alì, Greta; Rossini, Daniele; Merz, Valeria; Santoro, Raffaela; Zecchetto, Camilla; Zanotto, Marco; Di Nicolantonio, Federica; Bardelli, Alberto; Fontanini, Gabriella; Tortora, Giampaolo; Melisi, Davide
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 1-gen-2017 Carbone, Carmine; Di Gennaro, Elena; Piro, Geny; Milone, Maria Rita; Pucci, Biagio; Caraglia, Michele; Budillon, Alfredo
EMT and Treatment Resistance in Pancreatic Cancer 1-gen-2017 Gaianigo, Nicola; Melisi, Davide; Carbone, Carmine
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 1-gen-2017 Santoro, Raffaela; Carbone, Carmine; Piro, Geny; Chiao, Paul J; Melisi, Davide
Mostrati risultati da 1 a 20 di 41
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile